Paper39596237
The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy-Is It Time for Use in Everyday Practice?
Sieńko D and 9 others. Int J Mol Sci, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy-Is It Time for Use in Everyday Practice? Papers, record 39596237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy-Is It Time for Use in Everyday Practice?
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Diabetic Foot | Major topic |
| Wound Healing | Major topic |
| Humans | |
| Animals |
Source PubMed
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37583902 | Cell-based medicinal products approved in the European Union: current evidence and perspectives. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37583902 | PubMed |
| 2 | 33789737 | Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/33789737 | PubMed |
| 3 | 34020253 | Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p. | J Autoimmun | 2021 | https://conductscience.org/library/papers/34020253 | PubMed |
| 4 | 29867137 | Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. | Acta Pharmacol Sin | 2019 | https://conductscience.org/library/papers/29867137 | PubMed |
| 5 | 32826167 | Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: Phase I/2 safety study. | Foot Ankle Surg | 2021 | https://conductscience.org/library/papers/32826167 | PubMed |
| 6 | 19307751 | Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. | Exp Mol Med | 2009 | https://conductscience.org/library/papers/19307751 | PubMed |
| 7 | 36049265 | Health economics of diabetic foot ulcer and recent trends to accelerate treatment. | Foot (Edinb) | 2022 | https://conductscience.org/library/papers/36049265 | PubMed |
| 8 | 38252384 | Exploring the Role of Mesenchymal Stem Cell-Derived Exosomes in Diabetic and Chemotherapy-Induced Peripheral Neuropathy. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38252384 | PubMed |
| 9 | 33397467 | Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/33397467 | PubMed |
| 10 | 34439553 | Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34439553 | PubMed |
| 11 | 37712174 | Adipose-Derived Mesenchymal Stem Cell-Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37712174 | PubMed |
| 12 | 38186790 | 'Oxidative stress'-A new target in the management of diabetes mellitus. | J Family Med Prim Care | 2023 | https://conductscience.org/library/papers/38186790 | PubMed |
| 13 | 32938916 | Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. | Nat Commun | 2020 | https://conductscience.org/library/papers/32938916 | PubMed |
| 14 | 29996912 | Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research. | Stem Cell Res Ther | 2018 | https://conductscience.org/library/papers/29996912 | PubMed |
| 15 | 36691473 | Secretome of Mesenchymal Stromal Cells as a Possible Innovative Therapeutic Tool in Facial Nerve Injury Treatment. | Biomed Res Int | 2023 | https://conductscience.org/library/papers/36691473 | PubMed |
| 16 | 36970004 | Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities. | World J Clin Cases | 2023 | https://conductscience.org/library/papers/36970004 | PubMed |
| 17 | 27250101 | Hypoxia and Reactive Oxygen Species Homeostasis in Mesenchymal Progenitor Cells Define a Molecular Mechanism for Fracture Nonunion. | Stem Cells | 2016 | https://conductscience.org/library/papers/27250101 | PubMed |
| 18 | 37998356 | Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity. | Cells | 2023 | https://conductscience.org/library/papers/37998356 | PubMed |
| 19 | 32720751 | Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice. | Stem Cells Transl Med | 2020 | https://conductscience.org/library/papers/32720751 | PubMed |
| 20 | 22029655 | Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. | Cytotherapy | 2012 | https://conductscience.org/library/papers/22029655 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41602831 | Advancements in mesenchymal stem cell therapy for chronic wounds: challenges, innovations, and future directions. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41602831 | PubMed |
| 40654520 | Regenerative potential of PRP-based scaffolds in chronic wound healing: Mechanisms, advances, and therapeutic insights. | Regen Ther | 2025 | https://conductscience.org/library/papers/40654520 | PubMed |
| 40034318 | Unveiling distinctions between mesenchymal stromal cells and stem cells by single-cell transcriptomic analysis. | Heliyon | 2025 | https://conductscience.org/library/papers/40034318 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596237
GET https://conductscience.org/api/papers/v1/39596237/references?page=2